MCID: NNT012
MIFTS: 48

Neonatal Jaundice

Categories: Fetal diseases, Skin diseases

Aliases & Classifications for Neonatal Jaundice

Summaries for Neonatal Jaundice

Disease Ontology : 12 A pigmentation disease characterized by a high level of bilirubin in the blood, causing a yellowing of the skin and other tissues of a newborn infant.

MalaCards based summary : Neonatal Jaundice, also known as hyperbilirubinemia, neonatal, is related to kernicterus and pyruvate kinase deficiency of red cells, and has symptoms including icterus and newborn physiological jaundice. An important gene associated with Neonatal Jaundice is G6PD (Glucose-6-Phosphate Dehydrogenase), and among its related pathways/superpathways are Porphyrin and chlorophyll metabolism and Mineral absorption. The drugs Oxytocin and Sulfadoxine have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and liver.

Wikipedia : 75 Neonatal jaundice is a yellowish discoloration of the white part of the eyes and skin in a newborn baby... more...

Related Diseases for Neonatal Jaundice

Diseases related to Neonatal Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 201)
# Related Disease Score Top Affiliating Genes
1 kernicterus 33.3 UGT1A1 G6PD
2 pyruvate kinase deficiency of red cells 32.8 PKLR G6PD
3 glucosephosphate dehydrogenase deficiency 32.6 UGT1A1 SLCO1B1 G6PD
4 gilbert syndrome 30.5 UGT1A1 SLCO1B1 G6PD
5 cholestasis 30.3 UTP4 SLCO1B1 NR1I3
6 congenital nonspherocytic hemolytic anemia 30.3 PKLR G6PD
7 hemolytic anemia 30.2 SPTA1 PKLR G6PD
8 hereditary spherocytosis 29.5 UGT1A1 SPTA1 PKLR G6PD
9 bilirubin metabolic disorder 29.1 UGT1A1 SLCO1B1 OXT NR1I3 HMOX1 G6PD
10 pre-eclampsia 28.7 OXT IL6 HMOX1
11 anemia, nonspherocytic hemolytic, due to g6pd deficiency 11.5
12 alpha-1-antitrypsin deficiency 11.4
13 sialuria 11.3
14 north american indian childhood cirrhosis 11.3
15 stomatin-deficient cryohydrocytosis with neurologic defects 11.3
16 bamforth syndrome 11.3
17 bile acid synthesis defect, congenital, 4 11.1
18 niemann-pick disease, type c1 11.1
19 immunodeficiency 47 11.1
20 bile acid synthesis defect, congenital, 1 11.1
21 peroxisome biogenesis disorder 10b 11.1
22 hyperbilirubinemia, transient familial neonatal 10.7
23 biliary atresia 10.5
24 irinotecan toxicity 10.4 UGT1A1 SLCO1B1
25 pigmentation disease 10.3 UGT1A1 SLCO1B1
26 encephalopathy 10.3
27 plasmodium vivax malaria 10.2 IL6 G6PD
28 retinal artery occlusion 10.2 IL6 HMOX1
29 blood group incompatibility 10.2
30 acute bilirubin encephalopathy 10.2
31 bilirubin, serum level of, quantitative trait locus 1 10.1
32 rh isoimmunization 10.1
33 chronic bilirubin encephalopathy 10.1
34 rabies 10.1
35 acute cystitis 10.1
36 enterocolitis 10.1
37 pain agnosia 10.1
38 hypotonia 10.1
39 autism 10.0
40 cystic fibrosis 10.0
41 branchiootic syndrome 1 10.0
42 bile duct cysts 10.0
43 congenital hemolytic anemia 10.0 SPTA1 PKLR G6PD
44 alpha-thalassemia 10.0
45 patent ductus arteriosus 1 10.0
46 visual epilepsy 10.0
47 thrombocytopenia 10.0
48 perinatal necrotizing enterocolitis 10.0
49 cytokine deficiency 10.0
50 seizure disorder 10.0

Graphical network of the top 20 diseases related to Neonatal Jaundice:



Diseases related to Neonatal Jaundice

Symptoms & Phenotypes for Neonatal Jaundice

UMLS symptoms related to Neonatal Jaundice:


icterus, newborn physiological jaundice

Drugs & Therapeutics for Neonatal Jaundice

Drugs for Neonatal Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 92)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oxytocin Approved, Vet_approved Phase 4 50-56-6 439302 53477758
2
Sulfadoxine Approved, Investigational Phase 4 2447-57-6 17134
3
leucovorin Approved Phase 4 58-05-9 143 6006
4
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
5
Metformin Approved Phase 4 657-24-9 4091 14219
6
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
7 Oxytocics Phase 4
8 Anti-Infective Agents Phase 4
9 Folic Acid Antagonists Phase 4
10 Renal Agents Phase 4
11 Vitamin B9 Phase 4
12 Antiparasitic Agents Phase 4
13 Folate Phase 4
14 Vitamin B Complex Phase 4
15 Fanasil, pyrimethamine drug combination Phase 4
16 Antimalarials Phase 4
17 Anti-Infective Agents, Urinary Phase 4
18 Antiprotozoal Agents Phase 4
19
Scopolamine Approved, Investigational Phase 3 6533-68-2, 51-34-3 5184
20
Amodiaquine Approved, Investigational Phase 3 86-42-0 2165
21
Artesunate Approved, Investigational Phase 3 88495-63-0 5464098 6917864
22
Nifedipine Approved Phase 3 21829-25-4 4485
23
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
24
Dihydroartemisinin Experimental, Investigational Phase 3 71939-50-9 6918483
25
Piperaquine Experimental, Investigational Phase 3 4085-31-8 5079497
26 Neurotransmitter Agents Phase 3
27 Parasympatholytics Phase 3
28 Antiemetics Phase 3
29 Gastrointestinal Agents Phase 3
30 Cholinergic Agents Phase 3
31 Adjuvants, Anesthesia Phase 3
32 Muscarinic Antagonists Phase 3
33 Peripheral Nervous System Agents Phase 3
34 Cholinergic Antagonists Phase 3
35 Mydriatics Phase 3
36 Anesthetics Phase 3
37 Anticonvulsants Phase 3
38 Butylscopolammonium Bromide Phase 3
39 Bromides Phase 3
40 Autonomic Agents Phase 3
41 Tin mesoporphyrin Phase 3
42
Tin Phase 3 7440-31-5
43 Anthelmintics Phase 3
44 Artemisinins Phase 3
45 Artemisinine Phase 3
46 Antiviral Agents Phase 3
47 Hormones Phase 3
48 Calcium, Dietary Phase 3
49 Tocolytic Agents Phase 3
50 Vasodilator Agents Phase 3

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 Efficacy of Reverse Phototherapy With Super Light-emitting Diode(Super-led) in Term and Late Preterm Infants:Randomized and Controlled Clinical Trial Unknown status NCT01340339 Phase 4
2 Utilisation du Dispositif BBloo® Pour le Traitement de l'ictère néonatal : Satisfaction Des Parents et Des Personnels Soignants Unknown status NCT02156050 Phase 4
3 A Multicenter Study to Evaluate the Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency Unknown status NCT02594904 Phase 4 Yinzhihuang Oral Liquid
4 The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels .A Prospective Randomized Controlled Trial. Unknown status NCT02602301 Phase 4 Oxytocin
5 Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia Completed NCT00270530 Phase 4 Sulfadoxine-pyrimethamine (Fansidar)
6 Threshold for Initiation of Medical Treatment for Women With Gestational Diabetes: A Single Site Randomized Trial Not yet recruiting NCT03527537 Phase 4 Insulin;Glyburide;Metformin
7 Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes Withdrawn NCT00160485 Phase 4 Glyburide;Insulin
8 Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia Unknown status NCT03266913 Phase 3 Probiotic
9 Use of Hyoscine Butyl Bromide for Management of Prolonged Labor in Nulliparous Women, A Randomized Controlled Trial Unknown status NCT01854073 Phase 3 Hyoscine butyl bromide;Normal saline
10 A Randomized Trial of Aggressive or Conservative Phototherapy for Extremely Low Birth Weight Infants Completed NCT00114543 Phase 3
11 A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants. Completed NCT02685137 Phase 3 stannsoporfin
12 Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies? Completed NCT00295516 Phase 3
13 Efficacy, Safety and Tolerability of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Falciparum Malaria in Pregnancy: an Open-label, Randomised Controlled, Non-inferiority Trial Completed NCT01231113 Phase 3 artesunate-amodiaquine;Dihydroartemisinin-piperaquine
14 Study of Different Doses of Nifedipine to Treat Preterm Labor Terminated NCT00137501 Phase 3 Nifedipine
15 A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates Completed NCT01887327 Phase 2 stannsoporfin;Placebo
16 Effect of Oral Zinc Given Daily Between Days 2 and 7 of Life to Term or Near Term Neonates With Serum Bilirubin Levels of More Than 6 mg/dL at 24 ± 6 Hours of Life on Hyperbilirubinemia and Phototherapy Completed NCT00692224 Phase 1, Phase 2 zinc gluconate;placebo
17 Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia Completed NCT00004381 Phase 2 tin mesoporphyrin
18 Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus: An Open-label, Uncontrolled Clinical Trial Completed NCT03123562 Phase 2
19 An Open-Label Study of the Safety and Clinical Pharmacology of Stanate® in Infants At-Risk for Exchange Transfusion Completed NCT00115544 Phase 2 Stanate
20 Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants at Birth and Three Months of Age Completed NCT01081977 Phase 2
21 Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine Completed NCT00975689 Phase 1, Phase 2 N-Acetyl Cysteine
22 Effect of Ceftriaxone on Neonatal Jaundice Active, not recruiting NCT03133637 Phase 2 ceftriaxone
23 A Phase 2b, Multicenter, Single-dose, Blinded, Randomized, Placebo-controlled, Dose-escalation, Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia Terminated NCT00850993 Phase 2 stannsoporfin
24 Point-of-Care System for Determination of Bilirubin Capacity in Neonates Unknown status NCT02612207
25 Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants Unknown status NCT03237715
26 Comparison of the Efficacy of Phototherapy With Wavelength 478 vs. 459 nm for Treatment of Neonatal Jaundice Using Blue LED's. Unknown status NCT03183986
27 Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis in ABO-compatible and Incompatible Healthy Term Newborn Infants. Unknown status NCT00917007
28 Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment. Unknown status NCT02224586
29 Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia Unknown status NCT03074292
30 Comparison Between Turquoise and Blue Light in Treatment of Neonatal Jaundice Using Light Emission Diodes Completed NCT02154165
31 Comparison of Transcutaneous or Laboratory Measurement of Bilirubin in the Newborn Completed NCT01169740
32 Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates Completed NCT02612727
33 Transcutaneous Bilirubinometers in the Community and the Reduction of Morbidity Associated to Jaundice: A Clustered Randomized Controlled Trial. Completed NCT00735319
34 The Use of Glycerin Suppositories to Reduce Hyperbilirubinemia in Premature Infants Requiring Phototherapy Completed NCT01746511 glycerin suppository
35 Multicenter Prospective Study on the Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants Completed NCT01762189
36 Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates Completed NCT01434810
37 Neonatal Jaundice: Knowledge, Attitudes and Practices of Mothers and Medical Trainees and Providers in and Around Ogbomosho Completed NCT03306004
38 Development of Transcutaneous Bilirubin Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants: a Multicenter Study in China Completed NCT01763632
39 Implementation of a Transcutaneous Bilirubinometer in Jaundiced Newborns: a Randomised Controlled Trial Completed NCT01622699
40 Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia? Completed NCT03329040
41 Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study Completed NCT01599611
42 Neonatal, Clinical and Neurodevelopmental Outcome of Neonates Hospitalized for Neonatal Hyperbilirubinemia Reaching Exchange Transfusion Threshold in a Remote Setting Along the Thai-Myanmar Border Completed NCT02927093
43 A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202 Completed NCT02033096 Stannsoporfin;Placebo Control
44 Effects of Probiotics on Neonatal Hyperbilirubinemia Completed NCT02807246
45 Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia Completed NCT00801619
46 Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns Completed NCT02613676
47 Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Neonatal Jaundice Completed NCT03569254
48 An Evidence-based Strategy for Assessing the Risk of Significant Neonatal Hyperbilirubinemia Completed NCT01109277
49 BEST ABCs: Benefits and Effectiveness of Support Offered Through A Breastfeeding Clinic Study Completed NCT02043119
50 Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy Completed NCT02774434

Search NIH Clinical Center for Neonatal Jaundice

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Human Serum Albumin

Cochrane evidence based reviews: jaundice, neonatal

Genetic Tests for Neonatal Jaundice

Anatomical Context for Neonatal Jaundice

MalaCards organs/tissues related to Neonatal Jaundice:

41
Skin, Breast, Liver, Testes, Eye, Brain, Bone

Publications for Neonatal Jaundice

Articles related to Neonatal Jaundice:

(show top 50) (show all 2184)
# Title Authors PMID Year
1
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt. 9 38
20426517 2010
2
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. 9 38
20007901 2009
3
[Relationship between glucose-6-phosphate dehydrogenase gene mutations and neonatal jaundice in Naning, Guangxi]. 9 38
20113600 2009
4
Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease. 9 38
19925451 2009
5
A prolonged neonatal jaundice associated with a rare G6PD mutation. 9 38
19422023 2009
6
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). 9 38
18564698 2008
7
[Glucose-6-phosphate dehydrogenase deficiency: clinical presentation and eliciting factors]. 9 38
18547022 2008
8
Glucose-6-phosphate dehydrogenase deficiency. 9 38
18177777 2008
9
Cord blood bilirubin level in relation to bilirubin UDP-glucuronosyltransferase gene missense allele in Chinese neonates. 9 38
17888052 2007
10
A review of Orang Asli newborns admitted to a neonatal unit in a Malaysian general hospital. 9 38
17909678 2007
11
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets. 9 38
17489836 2007
12
The frequency of UDP-glucuronosyltransferase 1A1 promoter region (TA)7 polymorphism in newborns and it's relation with jaundice. 9 38
17166930 2007
13
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases. 9 38
17623517 2007
14
Prevalence of G6PD deficiency in newborns in the south of Brazil. 9 38
16792831 2006
15
[Role of genetic factors in occurrence of neonatal jaundice in Guangxi region]. 9 38
16255851 2005
16
Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies. 9 38
15910447 2005
17
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia. 9 38
16417692 2005
18
Screening for G71R mutation of the UGT1A1 gene in the Javanese-Indonesian and Malay-Malaysian populations. 9 38
15491385 2004
19
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. 9 38
14972648 2004
20
Glucose-6-phosphate dehydrogenase deficiency in neonates. 9 38
14703221 2003
21
Neonatology in Singapore: the way we were, the way forward. 9 38
12854374 2003
22
Glucose-6-phosphate dehydrogenase (G-6-PD) levels in jaundiced neonates in Calabar. 9 38
12956017 2003
23
Induction of bilirubin clearance by the constitutive androstane receptor (CAR). 9 38
12644704 2003
24
Oxytocin infusion in labor: the effect different indications and the use of different diluents on neonatal bilirubin levels. 9 38
12552319 2003
25
[Interest in the study of genetic variants of the promoter region of the UGT1A1 gene in neonatal jaundice]. 9 38
11827650 2002
26
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency. 9 38
11803413 2001
27
Neonatal jaundice--traditional Chinese medicine approach. 9 38
11803427 2001
28
A novel inhibitor of beta-glucuronidase: L-aspartic acid. 9 38
11568288 2001
29
Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates. 9 38
11581450 2001
30
Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency. 9 38
11783956 2001
31
A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. 9 38
11433050 2001
32
The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency. 9 38
11529386 2001
33
[Glucose-6-phosphate dehydrogenase et neonatal jaundice]. 9 38
11317924 2001
34
Molecular characterization of a German variant of glucose-6-phosphate dehydrogenase deficiency (G6PD Aachen). 9 38
10772881 2000
35
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese. 9 38
10502785 1999
36
A variant TATA box in the bilirubin UDP-glucuronosyltransferase 1 gene promoter does not contribute to neonatal jaundice in the Japanese population. 9 38
10507878 1999
37
Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. 9 38
10220506 1999
38
Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. 9 38
10190918 1999
39
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Al-Hofuf area. 9 38
17337961 1999
40
Glucose-6-phosphate dehydrogenase deficiency in Thailand; its significance in the newborn. 9 38
11400792 1999
41
Gilbert syndrome accelerates development of neonatal jaundice. 9 38
9580766 1998
42
Two new mutations of the glucose-6-phosphate dehydrogenase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and molecular relationships. 9 38
9332310 1997
43
[The preliminary study on prevention and treatment of neonatal jaundice]. 9 38
9596945 1997
44
Can severe neonatal jaundice be prevented by neonatal screening for glucose-6-phosphate dehydrogenase deficiency?--a review of evidence. 9 38
8942026 1996
45
G6PD NanKang (517 T-->C; 173 Phe-->Leu): a new Chinese G6PD variant associated with neonatal jaundice. 9 38
8807322 1996
46
G6PD: population genetics and clinical manifestations. 9 38
8861278 1996
47
The negative heritability of neonatal jaundice. 9 38
8835092 1996
48
Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. 9 38
8571933 1996
49
Enzyme deficiencies in neonates with jaundice. 9 38
8710395 1995
50
Role of hemolysis in neonatal jaundice associated with glucose-6 phosphate dehydrogenase deficiency. 9 38
7472840 1995

Variations for Neonatal Jaundice

Expression for Neonatal Jaundice

Search GEO for disease gene expression data for Neonatal Jaundice.

Pathways for Neonatal Jaundice

GO Terms for Neonatal Jaundice

Biological processes related to Neonatal Jaundice according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 response to hypoxia GO:0001666 9.54 PKLR HMOX2 HMOX1
2 response to cAMP GO:0051591 9.51 PKLR OXT
3 glutathione metabolic process GO:0006749 9.49 GSTM1 G6PD
4 regulation of angiogenesis GO:0045765 9.48 IL6 HMOX1
5 iron ion homeostasis GO:0055072 9.46 HMOX2 HMOX1
6 acute-phase response GO:0006953 9.43 UGT1A1 IL6
7 response to organic cyclic compound GO:0014070 9.43 UGT1A1 OXT G6PD
8 response to steroid hormone GO:0048545 9.4 UGT1A1 OXT
9 response to glucocorticoid GO:0051384 9.33 UGT1A1 OXT IL6
10 response to food GO:0032094 9.32 OXT G6PD
11 heme oxidation GO:0006788 8.96 HMOX2 HMOX1
12 heme catabolic process GO:0042167 8.8 UGT1A1 HMOX2 HMOX1

Molecular functions related to Neonatal Jaundice according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 heme oxygenase (decyclizing) activity GO:0004392 8.62 HMOX2 HMOX1

Sources for Neonatal Jaundice

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....